Jean-Michel Boers
Director Ejecutivo en Boehringer Ingelheim Pharmaceuticals, Inc. .
Perfil
Jean-Michel Boers is currently the President & Chief Executive Officer at Boehringer Ingelheim Pharmaceuticals, Inc. He previously served as the Chairman & Chief Executive Officer at Boehringer Ingelheim France SASU.
He holds an MBA from The University of Texas at Austin and a graduate degree from Radboud University Nijmegen.
Cargos activos de Jean-Michel Boers
| Empresas | Cargo | Inicio |
|---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Director Ejecutivo | 31/07/2020 |
Antiguos cargos conocidos de Jean-Michel Boers.
| Empresas | Cargo | Fin |
|---|---|---|
Boehringer Ingelheim France SASU
 Boehringer Ingelheim France SASU Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim France SAS engages in the research, development, marketing, and distribution of pharmaceuticals. The company was founded on October 31, 1986 and is headquartered in Paris, France. | Director Ejecutivo | - |
Formación de Jean-Michel Boers.
| Radboud University Nijmegen | Graduate Degree |
| The University of Texas at Austin | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Boehringer Ingelheim France SASU
Boehringer Ingelheim France SASU Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim France SAS engages in the research, development, marketing, and distribution of pharmaceuticals. The company was founded on October 31, 1986 and is headquartered in Paris, France. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
- Bolsa de valores
- Insiders
- Jean-Michel Boers
